Delhi-based Dr Dangs Lab selected as central lab for Covaxin human clinical trials

"We are extremely privileged to announce that Dr. Dangs Lab, New Delhi has been provided the opportunity to serve the nation by being selected as the central lab for the Human Clinical trials of Covaxin; India's indigenous COVID-19 vaccine being developed and manufactured by Bharat Biotech in collaboration with the ICMR - NIV," it said in a statement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2CYoAi4
via IFTTT